Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.77B |
| 2 |
McKesson
MCK
|
+$2.38B |
| 3 |
SPCX
SpaceX
SPCX
|
+$2.3B |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$2.05B |
| 5 |
Amazon
AMZN
|
+$1.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.96B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$3.11B |
| 3 |
Honeywell
HON
|
+$1.96B |
| 4 |
Salesforce
CRM
|
+$1.47B |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$775M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.63% |
| 2 | Financials | 9.78% |
| 3 | Healthcare | 7.32% |
| 4 | Industrials | 7.25% |
| 5 | Consumer Discretionary | 7.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36.8B
| $590M | 0.03% |
9,712,590
+338,120
| +4% | +$20.2M |
|
502
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.86B
| $590M | 0.03% |
3,991,007
-49,737
| -1% | -$7.04M |
|
503
JPMorgan Core Plus Bond ETF
JCPB
$14.6B
| $588M | 0.03% |
12,525,713
+4,163,299
| +50% | +$195M |
|
504
Ingersoll Rand
IR
$30.5B
| $585M | 0.03% |
7,136,789
-916,026
| -11% | -$70.9M |
|
505
Brookfield
BN
$94B
| $585M | 0.03% |
13,738,306
+2,903,439
| +27% | +$130M |
|
506
Scotiabank
BNS
$113B
| $584M | 0.03% |
6,724,105
+2,595,889
| +63% | +$204M |
|
507
Mizuho Financial
MFG
$126B
| $584M | 0.03% |
60,949,488
+1,165,673
| +2% | +$10.5M |
|
508
Martin Marietta Materials
MLM
$37.8B
| $584M | 0.03% |
1,012,016
-329,585
| -25% | -$195M |
|
509
W.R. Berkley
WRB
$25.4B
| $582M | 0.03% |
8,252,790
-2,159,675
| -21% | -$145M |
|
510
Unilever
UL
$140B
| $581M | 0.03% |
9,665,376
+305,781
| +3% | +$17.7M |
|
511
Lennox International
LII
$13.4B
| $581M | 0.03% |
1,013,833
-75,387
| -7% | -$38.4M |
|
512
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.72B
| $579M | 0.03% |
3,750,615
+1,645,863
| +78% | +$275M |
|
513
Avery Dennison
AVY
$13.6B
| $576M | 0.03% |
3,546,264
-90,490
| -2% | -$14.7M |
|
514
Edwards Lifesciences
EW
$52.4B
| $573M | 0.03% |
6,339,368
-721,508
| -10% | -$60.4M |
|
515
Invesco S&P 500 Momentum ETF
SPMO
$21.9B
| $572M | 0.03% |
3,538,672
+410,765
| +13% | +$57.9M |
|
516
VeriSign
VRSN
$26.6B
| $571M | 0.03% |
2,269,680
-38,974
| -2% | -$10.8M |
|
517
West Pharmaceutical
WST
$24.5B
| $568M | 0.03% |
1,582,546
+124,264
| +9% | +$38M |
|
518
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$6.68B
| $568M | 0.03% |
5,892,599
-359,077
| -6% | -$34.6M |
|
519
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.18B
| $567M | 0.03% |
3,174,467
-15,951
| -0.5% | -$2.58M |
|
520
Halliburton
HAL
$28.2B
| $566M | 0.03% |
16,656,929
-601,985
| -3% | -$23.5M |
|
521
Keurig Dr Pepper
KDP
$43.3B
| $562M | 0.03% |
17,161,687
-9,443,339
| -35% | -$275M |
|
522
ON Semiconductor
ON
$28.2B
| $559M | 0.03% |
5,917,224
-190,029
| -3% | -$19.5M |
|
523
Iron Mountain
IRM
$36B
| $559M | 0.03% |
4,426,922
-225,325
| -5% | -$27.6M |
|
|
NVO
524
Novo Nordisk
NVO
$215B
| $559M | 0.03% |
11,659,869
+790,669
| +7% | +$34M |
|
525
Old Dominion Freight Line
ODFL
$41.1B
| $558M | 0.03% |
2,575,926
-755,329
| -23% | -$163M |
|
Similar funds
Morgan Stanley's Q2 2026 Portfolio in Review
As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2026 filing shows 423 new, 3,809 increased, 3,216 reduced and 305 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
- Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
- Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
- Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
- Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
- Morgan Stanley opened 423 new positions and closed 305 in Q2 2026.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.